Larry Schlabach
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 6
- Cancer Treatment and Pharmacology 2
- Lung Cancer Research Studies 2
- HER2/EGFR in Cancer Research 1
-
- Lung Cancer Treatments and Mutations 2
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- David H. Johnson (3 shared papers)Yu Shyr (5 shared papers)Hak Choy (2 shared papers)Russell F. DeVore (2 shared papers)F. Yunus (3 shared papers)Kenneth R. Hande (2 shared papers)Furhan Yunus (1 shared paper)Lester L. Porter (1 shared paper)
- Journals
- Annals of Oncology (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Cancer Research (1 paper)The Lancet Oncology (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United StatesTaiwan
In The Last Decade
Larry Schlabach
9 papers receiving 753 citations
Larry Schlabach's Hit Papers
Peers
Comparison fields: 5 of 61
- Oncology 461
- Cancer Research 163
- Pulmonary and Respiratory Medicine 257
- Radiology, Nuclear Medicine and Imaging 110
- Genetics 44
Countries citing papers authored by Larry Schlabach
This map shows the geographic impact of Larry Schlabach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Schlabach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Schlabach more than expected).
Fields of papers citing papers by Larry Schlabach
This network shows the impact of papers produced by Larry Schlabach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Schlabach. The network helps show where Larry Schlabach may publish in the future.
Co-authors
The 25 scholars most cited alongside Larry Schlabach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 2 | 2000 | 87 | |
| 3 | 2004 | 75 | |
| 4 | In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity. | 1993 | 41 |
| 5 | Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study. | 2001 | 36 |
| 6 | 2014 | 31 | |
| 7 | Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer. | 1997 | 18 |
| 8 | 2009 | 18 | |
| 9 | 2011 | 5 |
About Larry Schlabach
Larry Schlabach is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Hematology and Cancer Research, having authored 9 papers that have together received 772 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (2 papers), Cancer Treatment and Pharmacology (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Lung Cancer Research Studies (2 papers), Acute Myeloid Leukemia Research (1 paper), Cancer Genomics and Diagnostics (1 paper), HER2/EGFR in Cancer Research (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Oncology (461 citations), Cancer Research (163 citations), Pulmonary and Respiratory Medicine (257 citations), Radiology, Nuclear Medicine and Imaging (110 citations) and Genetics (44 citations). Larry Schlabach has collaborated with scholars based in United States and Taiwan. Frequent co-authors include David H. Johnson, Yu Shyr, Hak Choy, Russell F. DeVore, F. Yunus, Kenneth R. Hande, Furhan Yunus, Lester L. Porter, Pradip K. Rustagi and Bruce Evan Johnson. Their work appears in journals such as Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancer Research, The Lancet Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.